retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial The TRIUMPH-1 Phase 3 results

This decline was assessed using C-peptide, which serves as a surrogate marker for cell function

The intestinal lining serves as the boundary between the outside world and your internal environment, and the immune cells stationed there must constantly distinguish between harmless food particles, beneficial bacteria, and genuine threats

The ADA/EASD consensus report 4 highlights the use of DDP-4 inhibitors when intermediate efficacy for glucose lowering is required and where weight management goals would prefer a weight-neutral approach

Melatonin mitigates mitochondrial malfunction

, ,

[52] Rollet M, Bohn T, Vahid F, On Behalf Of The Oriscav Working Group